GLPBio

Pain Research

Products Related to Pain Research(225)

  • GC41181 structure
    GC41181LY2183240 2'-isomer
    CAS: 1010096-65-7
    Purity: >98.00%

    LY2183240 is a potent, competitive small molecule inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.

  • GC41191 structure
    GC41191(±)13(14)-EpDPA
    CAS: 895127-64-7
    Purity: >95.00%

    Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers.

  • GC41203 structure
    GC41203(±)7(8)-EpDPA
    CAS: 895127-66-9
    Purity: >95.00%

    Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina.

  • GC41270 structure
    GC41270N-desmethyl Zolmitriptan
    CAS: 139264-35-0
    Purity: >95.00%

    N-desmethyl Zolmitriptan (DZT) is an active metabolite of the serotonin (5-HT) receptor subtype 5-HT1B and 5-HT1D agonist zolmitriptan.

  • GC41499 structure
    GC41499α-Phellandrene
    CAS: 99-83-2
    Purity: >80.00%

    α-Phellandrene is a cyclic monoterpene that has been found in various plants, including Cannabis, and has diverse biological activities.

  • GC41599 structure
    GC41599URB754
    CAS: 86672-58-4
    Purity: >98.00%

    URB754 is a potent and noncompetitive inhibitor of monoacylglycerol lipase (MAGL), exhibiting an IC50 value of 200 nM for the recombinant rat brain enzyme.

  • GC41685 structure
    GC41685(±)-WIN 55,212 (mesylate)
    CAS: 137795-17-6
    Purity: >98.00%

    (±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively.

  • GC41697 structure
    GC41697(Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt)
    Purity: >95.00%

    (Ala1)-PAR4 (1-6) amide (mouse) is a peptide agonist of proteinase-activated receptor 4 (PAR4) that induces aggregation of rat and human platelets in vitro (EC50s = 15 and 60 μM, respectively).

  • GC42258 structure
    GC422583-Cysteinylacetaminophen (trifluoroacetate salt)
    CAS: 1331891-93-0
    Purity: >98.00%

    An acetaminophen-protein adduct

  • GC42402 structure
    GC424024-hydroxy (S)-Duloxetine β-D-Glucuronide (sodium salt)
    Purity: >95.00%

    4-hydroxy (S)-Duloxetine β-D-glucuronide is an inactive metabolite of the serotonin and norepinephrine reuptake inhibitor (S)-duloxetine.

  • GC42550 structure
    GC425505-hydroxy-6-methoxy (S)-Duloxetine
    CAS: 741693-79-8
    Purity: >95.00%

    5-hydroxy-6-methoxy (S)-Duloxetine is a metabolite of (S)-duloxetine.

  • GC42580 structure
    GC425806-hydroxy Chlorzoxazone
    CAS: 1750-45-4
    Purity: >97.00%

    6-hydroxy Chlorzoxazone is the primary metabolite of Chlorzoxazone in vivo. 6-hydroxy Chlorzoxazone is mainly formed through the hepatic cytochrome P450 enzyme system and is commonly used as a probe in biochemical research to quantitatively evaluate CYP2E1 activity.

  • GC42693 structure
    GC42693Acetaminophen Glucuronide (sodium salt)
    CAS: 120595-80-4
    Purity: >98.00%

    Acetaminophen glucuronide is an inactive metabolite of the analgesic and antipyretic agent acetaminophen.

  • GC42694 structure
    GC42694Acetaminophen sulfate (potassium salt)
    CAS: 32113-41-0
    Purity: >98.00%

    Acetaminophen sulfate is a metabolite of acetaminophen.

  • GC42704 structure
    GC42704Acetyl β-Endorphin (human) (trifluoroacetate salt)
    Purity: >95.00%

    Acetyl β-endorphin is an acetylated derivative of β-endorphin that binds to opioid receptors in rat caudal dorsomedial medulla (Ki = 490 nM) and mouse brain membrane preparations (IC50 = 109 nM).

  • GC42809 structure
    GC42809Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt)
    Purity: >95.00%

    Angiotensin II (3-8) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II.

  • GC42865 structure
    GC42865AT-121
    CAS: 2099681-31-7
    Purity: >95.00%

    AT-121 is a dual μ-opioid and nociceptin receptor partial agonist (Kis = 16.49 and 3.67 nM, respectively).

  • GC42885 structure
    GC42885AX 048
    CAS: 873079-69-7
    Purity: >98.00%

    The group IVA phospholipase A2 (PLA2), known as calcium-dependent cytosolic PLA2 (cPLA2), selectively releases arachidonic acid from membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins and leukotrienes.

  • GC42934 structure
    GC42934Biocytin-β-Endorphin (human) (trifluoroacetate salt)
    Purity: >95.00%

    Biocytin-β-endorphin is a form of β-endorphin that is conjugated to biocytin.

  • GC42990 structure
    GC42990Bupivacaine
    CAS: 38396-39-3
    Purity: >98.00%

    Bupivacaine is a sodium channel blocker and local anesthetic.

  • GC43155 structure
    GC43155CAY10448
    CAS: 1177195-52-6
    Purity: >98.00%

    Capsaicin is the primary active component of the heat and pain-eliciting lipid soluble fraction of the Capsicum pepper.

  • GC43171 structure
    GC43171CAY10568
    CAS: 22913-17-3
    Purity: >98.00%

    Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons.

  • GC43216 structure
    GC43216CCR4 Antagonist (hydrochloride)
    CAS: 1784252-84-1
    Purity: >98.00%

    CCR4 antagonist is an antagonist of CC chemokine receptor 4 (CCR4) that inhibits human CCL22-derived [35S]GTPγS and [125I]CCL22 binding in vitro (IC50s = 19 and 70 nM, respectively).

  • GC43327 structure
    GC43327CTAP (trifluoroacetate salt)
    Purity: >98.00%

    CTAP is a water soluble, cyclic octapeptide which acts as a receptor antagonist that is selective for the μ opioid receptor (IC50 = 3.5 nM) over the δ receptor (IC50 = 4,500 nM).